Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytosis Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Dermatophytosis Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatophytosis Drugs Market Perspective (2018-2029)
2.2 Dermatophytosis Drugs Growth Trends by Region
2.2.1 Global Dermatophytosis Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dermatophytosis Drugs Historic Market Size by Region (2018-2024)
2.2.3 Dermatophytosis Drugs Forecasted Market Size by Region (2024-2029)
2.3 Dermatophytosis Drugs Market Dynamics
2.3.1 Dermatophytosis Drugs Industry Trends
2.3.2 Dermatophytosis Drugs Market Drivers
2.3.3 Dermatophytosis Drugs Market Challenges
2.3.4 Dermatophytosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatophytosis Drugs Players by Revenue
3.1.1 Global Top Dermatophytosis Drugs Players by Revenue (2018-2024)
3.1.2 Global Dermatophytosis Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Dermatophytosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatophytosis Drugs Revenue
3.4 Global Dermatophytosis Drugs Market Concentration Ratio
3.4.1 Global Dermatophytosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytosis Drugs Revenue in 2022
3.5 Dermatophytosis Drugs Key Players Head office and Area Served
3.6 Key Players Dermatophytosis Drugs Product Solution and Service
3.7 Date of Enter into Dermatophytosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatophytosis Drugs Breakdown Data by Type
4.1 Global Dermatophytosis Drugs Historic Market Size by Type (2018-2024)
4.2 Global Dermatophytosis Drugs Forecasted Market Size by Type (2024-2029)
5 Dermatophytosis Drugs Breakdown Data by Application
5.1 Global Dermatophytosis Drugs Historic Market Size by Application (2018-2024)
5.2 Global Dermatophytosis Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Dermatophytosis Drugs Market Size (2018-2029)
6.2 North America Dermatophytosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dermatophytosis Drugs Market Size by Country (2018-2024)
6.4 North America Dermatophytosis Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatophytosis Drugs Market Size (2018-2029)
7.2 Europe Dermatophytosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dermatophytosis Drugs Market Size by Country (2018-2024)
7.4 Europe Dermatophytosis Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatophytosis Drugs Market Size (2018-2029)
8.2 Asia-Pacific Dermatophytosis Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dermatophytosis Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Dermatophytosis Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatophytosis Drugs Market Size (2018-2029)
9.2 Latin America Dermatophytosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dermatophytosis Drugs Market Size by Country (2018-2024)
9.4 Latin America Dermatophytosis Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatophytosis Drugs Market Size (2018-2029)
10.2 Middle East & Africa Dermatophytosis Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dermatophytosis Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Dermatophytosis Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Dermatophytosis Drugs Introduction
11.1.4 Novartis Revenue in Dermatophytosis Drugs Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Dermatophytosis Drugs Introduction
11.2.4 Pfizer Revenue in Dermatophytosis Drugs Business (2018-2024)
11.2.5 Pfizer Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Detail
11.3.2 Sanofi-Aventis Business Overview
11.3.3 Sanofi-Aventis Dermatophytosis Drugs Introduction
11.3.4 Sanofi-Aventis Revenue in Dermatophytosis Drugs Business (2018-2024)
11.3.5 Sanofi-Aventis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Dermatophytosis Drugs Introduction
11.4.4 Merck Revenue in Dermatophytosis Drugs Business (2018-2024)
11.4.5 Merck Recent Development
11.5 Enzon Pharmaceuticals
11.5.1 Enzon Pharmaceuticals Company Detail
11.5.2 Enzon Pharmaceuticals Business Overview
11.5.3 Enzon Pharmaceuticals Dermatophytosis Drugs Introduction
11.5.4 Enzon Pharmaceuticals Revenue in Dermatophytosis Drugs Business (2018-2024)
11.5.5 Enzon Pharmaceuticals Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Dermatophytosis Drugs Introduction
11.6.4 Bayer Revenue in Dermatophytosis Drugs Business (2018-2024)
11.6.5 Bayer Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Detail
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Dermatophytosis Drugs Introduction
11.7.4 Astellas Pharma Revenue in Dermatophytosis Drugs Business (2018-2024)
11.7.5 Astellas Pharma Recent Development
11.8 GSK
11.8.1 GSK Company Detail
11.8.2 GSK Business Overview
11.8.3 GSK Dermatophytosis Drugs Introduction
11.8.4 GSK Revenue in Dermatophytosis Drugs Business (2018-2024)
11.8.5 GSK Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Dermatophytosis Drugs Introduction
11.9.4 Abbott Revenue in Dermatophytosis Drugs Business (2018-2024)
11.9.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Dermatophytosis Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Rx
Table 3. Key Players of OTC
Table 4. Global Dermatophytosis Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Dermatophytosis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dermatophytosis Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Dermatophytosis Drugs Market Share by Region (2018-2024)
Table 8. Global Dermatophytosis Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Dermatophytosis Drugs Market Share by Region (2024-2029)
Table 10. Dermatophytosis Drugs Market Trends
Table 11. Dermatophytosis Drugs Market Drivers
Table 12. Dermatophytosis Drugs Market Challenges
Table 13. Dermatophytosis Drugs Market Restraints
Table 14. Global Dermatophytosis Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Dermatophytosis Drugs Market Share by Players (2018-2024)
Table 16. Global Top Dermatophytosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytosis Drugs as of 2022)
Table 17. Ranking of Global Top Dermatophytosis Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Dermatophytosis Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatophytosis Drugs Product Solution and Service
Table 21. Date of Enter into Dermatophytosis Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermatophytosis Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Dermatophytosis Drugs Revenue Market Share by Type (2018-2024)
Table 25. Global Dermatophytosis Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Dermatophytosis Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Dermatophytosis Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Dermatophytosis Drugs Revenue Market Share by Application (2018-2024)
Table 29. Global Dermatophytosis Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Dermatophytosis Drugs Revenue Market Share by Application (2024-2029)
Table 31. North America Dermatophytosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Dermatophytosis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Dermatophytosis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Dermatophytosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Dermatophytosis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Dermatophytosis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Dermatophytosis Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Dermatophytosis Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Dermatophytosis Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Dermatophytosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Dermatophytosis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Dermatophytosis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Dermatophytosis Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Dermatophytosis Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Dermatophytosis Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Dermatophytosis Drugs Product
Table 49. Novartis Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Dermatophytosis Drugs Product
Table 54. Pfizer Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Sanofi-Aventis Company Detail
Table 57. Sanofi-Aventis Business Overview
Table 58. Sanofi-Aventis Dermatophytosis Drugs Product
Table 59. Sanofi-Aventis Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 60. Sanofi-Aventis Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Dermatophytosis Drugs Product
Table 64. Merck Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Enzon Pharmaceuticals Company Detail
Table 67. Enzon Pharmaceuticals Business Overview
Table 68. Enzon Pharmaceuticals Dermatophytosis Drugs Product
Table 69. Enzon Pharmaceuticals Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 70. Enzon Pharmaceuticals Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Dermatophytosis Drugs Product
Table 74. Bayer Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Astellas Pharma Company Detail
Table 77. Astellas Pharma Business Overview
Table 78. Astellas Pharma Dermatophytosis Drugs Product
Table 79. Astellas Pharma Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 80. Astellas Pharma Recent Development
Table 81. GSK Company Detail
Table 82. GSK Business Overview
Table 83. GSK Dermatophytosis Drugs Product
Table 84. GSK Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 85. GSK Recent Development
Table 86. Abbott Company Detail
Table 87. Abbott Business Overview
Table 88. Abbott Dermatophytosis Drugs Product
Table 89. Abbott Revenue in Dermatophytosis Drugs Business (2018-2024) & (US$ Million)
Table 90. Abbott Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytosis Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Dermatophytosis Drugs Market Share by Type: 2022 VS 2029
Figure 3. Rx Features
Figure 4. OTC Features
Figure 5. Global Dermatophytosis Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Dermatophytosis Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Dermatophytosis Drugs Report Years Considered
Figure 11. Global Dermatophytosis Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dermatophytosis Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dermatophytosis Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global Dermatophytosis Drugs Market Share by Players in 2022
Figure 15. Global Top Dermatophytosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytosis Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dermatophytosis Drugs Revenue in 2022
Figure 17. North America Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dermatophytosis Drugs Market Share by Country (2018-2029)
Figure 19. United States Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Dermatophytosis Drugs Market Share by Country (2018-2029)
Figure 23. Germany Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Dermatophytosis Drugs Market Share by Region (2018-2029)
Figure 31. China Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Dermatophytosis Drugs Market Share by Country (2018-2029)
Figure 39. Mexico Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Dermatophytosis Drugs Market Share by Country (2018-2029)
Figure 43. Turkey Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Dermatophytosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 46. Pfizer Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 47. Sanofi-Aventis Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 48. Merck Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 49. Enzon Pharmaceuticals Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 50. Bayer Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 51. Astellas Pharma Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 52. GSK Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 53. Abbott Revenue Growth Rate in Dermatophytosis Drugs Business (2018-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed